Wednesday, October 14, 2026

AvalonBay Communities Already 5% Up, Almost One Hour Before The NYSE Open

ViaNews Editorial Team

February 21, 2023

AvalonBay Communities Already 5% Up, Almost One Hour Before The NYSE Open

(VIANEWS) - The NYSE opens in less than one hour and AvalonBay Communities's pre-market value is already 5% up.

AvalonBay Communities's last close was $179.27, 30.8% below its 52-week high of $259.05.

The last session, NYSE finished with AvalonBay Communities (AVB) dropping 0.47% to $179.27. NYSE dropped 0.21% to $15,840.16, after four sequential sessions in a row of losses, on what was a somewhat down trend trading session.

About AvalonBay Communities

As of December 31, 2020, the Company owned or held a direct or indirect ownership interest in 291 apartment communities containing 86,025 apartment homes in 11 states and the District of Columbia, of which 18 communities were under development and one community was under redevelopment. The Company is an equity REIT in the business of developing, redeveloping, acquiring and managing apartment communities in leading metropolitan areas in New England, the New York/New Jersey Metro area, the Mid-Atlantic, the Pacific Northwest, and Northern and Southern California, as well as in the Company's expansion markets consisting of Southeast Florida and Denver, Colorado (the "Expansion Markets").

Earnings Per Share

As for profitability, AvalonBay Communities has a trailing twelve months EPS of $5.72.

PE Ratio

AvalonBay Communities has a trailing twelve months price to earnings ratio of 31.34. Meaning, the purchaser of the share is investing $31.34 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.18%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Mar 29, 2023, the estimated forward annual dividend rate is 6.6 and the estimated forward annual dividend yield is 3.66%.

More news about AvalonBay Communities (AVB).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,372 source documents archived
Query this data → isubstrate.com